These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 15926192

  • 1. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA-8159, a new erectogenic, in rats.
    Kim YC, Shim HJ, Lee JH, Kim SH, Kwon JW, Kim WB, Lee MG.
    Biopharm Drug Dispos; 2005 Sep; 26(6):233-41. PubMed ID: 15926192
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Negligible pharmacokinetic interaction between oral DA-8159, a new erectogenic, and amlodipine in rats.
    Lee JH, Kim EJ, Kwon JW, Yoo M, Lee MG.
    Biopharm Drug Dispos; 2006 Apr; 27(3):125-31. PubMed ID: 16400709
    [Abstract] [Full Text] [Related]

  • 4. Effects of enzyme inducers and inhibitors on the pharmacokinetics of metformin in rats: involvement of CYP2C11, 2D1 and 3A1/2 for the metabolism of metformin.
    Choi YH, Lee MG.
    Br J Pharmacol; 2006 Oct; 149(4):424-30. PubMed ID: 16940989
    [Abstract] [Full Text] [Related]

  • 5. Effects of enzyme inducers or inhibitors on the pharmacokinetics of intravenous parathion in rats.
    Hurh E, Lee E, Lee A, Kim Y, Kim S, Kim S, Lee M.
    Biopharm Drug Dispos; 2000 Jul; 21(5):193-204. PubMed ID: 11180198
    [Abstract] [Full Text] [Related]

  • 6. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous omeprazole in rats.
    Lee DY, Shin HS, Bae SK, Lee MG.
    Biopharm Drug Dispos; 2006 Jul; 27(5):209-18. PubMed ID: 16586464
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA-8159, an erectogenic, in rats.
    Oh EY, Bae SK, Kwon JW, You M, Lee DC, Lee MG.
    Br J Pharmacol; 2007 May; 151(1):24-34. PubMed ID: 17351661
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic interaction between DA-8159, a new erectogenic, and metformin in rats: competitive inhibition of metabolism via hepatic CYP3A1/2.
    Choi YH, Chung SJ, Lee MG.
    Br J Pharmacol; 2008 Apr; 153(7):1568-78. PubMed ID: 18204480
    [Abstract] [Full Text] [Related]

  • 13. Effects of water deprivation on the pharmacokinetics of DA-8159, a new erectogenic, in rats.
    Kim JY, Kim YC, Lee MG, Kwon JW, Yoo M.
    J Pharm Pharm Sci; 2006 Apr; 9(1):10-21. PubMed ID: 16849004
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats.
    Chung HJ, Choi YH, Kim SH, Lee MG.
    J Pharm Pharmacol; 2006 Apr; 58(4):449-57. PubMed ID: 16597362
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic interaction between 5-[2-propyloxy-5-(1-methyl-2-pyrollidinylethylamidosulfonyl)phenyl]-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo (4,3-d) pyrimidine-7-one (DA-8159) and nitroglycerin in rats.
    Lee SJ, Bae SK, Kwon JW, You M, Lee DC, Lee MG.
    J Pharm Pharmacol; 2005 Nov; 57(11):1397-405. PubMed ID: 16259771
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.